| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Rohit Arora | |
| Bramah Singh | |||
| Pirouz Parang | |||
| P2860 | cites work | The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase | Q28373346 |
| Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation | Q28578053 | ||
| Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass | Q34277953 | ||
| Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial | Q34544699 | ||
| Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina | Q34547211 | ||
| Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials | Q35091375 | ||
| Metabolic manipulation in ischaemic heart disease, a novel approach to treatment | Q35745797 | ||
| A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction | Q36680433 | ||
| Ranolazine: a novel metabolic modulator for the treatment of angina | Q41749098 | ||
| Effects of ribose on exercise-induced ischaemia in stable coronary artery disease | Q43575017 | ||
| Effects of propionyl-L-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart | Q43621377 | ||
| Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand | Q43811969 | ||
| Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine | Q43873826 | ||
| Brief increase in carbohydrate oxidation after reperfusion reverses myocardial stunning in conscious pigs | Q44228476 | ||
| Treatment of stable angina with low dose diltiazem in combination with the metabolic agent trimetazidine | Q44378569 | ||
| The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase | Q44517382 | ||
| Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase | Q44517385 | ||
| D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study | Q44648431 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 217-223 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Journal of Cardiovascular Pharmacology and Therapeutics | Q1855644 |
| P1476 | title | Metabolic modulators for chronic cardiac ischemia | |
| P478 | volume | 10 |
| Q47439420 | Caffeoylxanthiazonoside exerts cardioprotective effects during chronic heart failure via inhibition of inflammatory responses in cardiac cells |
| Q40950605 | Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat. |
| Q38217985 | Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease. |
| Q36860611 | Metabonomic strategy to the evaluation of chinese medicine compound danshen dripping pills interfering myocardial ischemia in rats |
| Q26769979 | Post-Translational Modifications of Cardiac Mitochondrial Proteins in Cardiovascular Disease: Not Lost in Translation |
| Q37457580 | Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy |
Search more.